Category Archives: Lexaria Bioscience Corp. LXRP

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) Revolutionary Process Creates Superior Cannabinoid Edibles

Disruptive, patented technology is set to revolutionize the edible cannabis market Company has patent applications in 45 countries, including 18 applications in the U.S. Technology is patent-protected for CBD and all other non-psychoactive cannabinoids, with patents pending for THC, other psychoactive cannabinoids, NSAIDs, nicotine and other molecules A common complaint among the consumers of cannabis […]

Regulation Forcing Drug and Cigarette Companies to Be More Responsible is Great News for Lexaria (LXRP), says CEO

In an interview with Stock Day, CEO Chris Bunka of Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) discussed the company’s recent achievements and its plans for the near future. Revenues are climbing, exceeding, so far in 2017, the total for all of 2016, and the potential for further increases is imminent. The company is in […]

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Praised in Technical420 Article

Lexaria Bioscience Corp. featured in a Technical420 article praising the company’s recent developments Lexaria is improving and strengthening patent portfolio; 19 patent applications are pending in more than 40 countries Company executes partnership with NeutriSci International; joint venture allows LXRP to enter Asian market Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), an innovative company licensing […]

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) Technology Offers More Potent Delivery of Cannabinoids

Technology that improves bioavailability of orally ingested cannabinoids Safer approach that mitigates risks from carcinogens Generates revenue by out-licensing its technology internationally Announcement of a new government initiative to reduce the level of nicotine in cigarettes to nonaddictive levels is good news for Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP). Less addictive cigarettes mean less dependence […]

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Sees New Round of Investors Attracted to Cannabis Market

Has patents in the United States and Australia and patents pending in more than 40 countries for proprietary technology easing how edible cannabinoids enter body Revenue stream comes from own products and 5-10% margin of gross sales from licensing technology to third parties Signed C$250,000 joint venture agreement with National Research Council (NRC) in Canada […]

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Set to Benefit as Study Shows More Benefits of Cannabidiol

Cannabidiol (CBD) combats anxiety, inflammation, nausea and vomiting Low side-effect profile means high doses of cannabidiol can be used for treatment of schizophrenia, dementia, diabetes and nausea Lower doses promote and maintain health with anti-oxidative, anti-inflammatory and neuroprotective effects Lexaria Bioscience Corp. set to benefit from increasing interest in CBD as patented technology improves taste, […]

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) Patented Cannabinoid Delivery System Approved

Patented lipophilic delivery system increases bio-absorption Patents cover broad range of lipophilic bio-actives, including cannabinoids, vitamins, other pharma 19 patents filed across 44 countries First international patent issued and approved in Australia Any argument over the efficacy of medicinal marijuana is settled science. Recent prestigious clinical studies have provided conclusive evidence that medical cannabinoids are […]

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Well-positioned For Expanding Canadian Cannabinoid Market

Lexaria Bioscience Corp. well-positioned for growth in expanding Canadian cannabinoid market Canadian market for cannabis extracts and oils expected to top C$1.6 billion by 2020 Company’s patented technology infuses organically sourced hemp oil into molecules of other substances such as lipids, the basis of the human endocannabinoid system Patented technology enables better-tasting hemp oil-infused gourmet […]

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is “One to Watch”

Revenue-generating biosciences company focused on improving the delivery of bioactive compounds through gourmet foods Proprietary technology shown to enhance the bioavailability of orally ingested cannabinoids while improving the taste Actively developing and selling hemp oil-based gourmet food products through consumer brands ViPova™ and Lexaria Energy Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed and […]

Stay Connected

Sign up to receive the latest market news, perspectives on clients, and ongoing DTN announcements. Via our newsletter, you will also learn highly effective marketing strategies and ways to properly exposure your brand.